LIPIGON PHARMACEUTICALS
Lipigon Pharmaceuticals is specialized in fat metabolism and develops new blood lipids. Lipigon is currently focusing on developing drugs directed against the enzyme lipoprotein lipase (LPL). People with low activity at LPL have a higher incidence of elevated blood fats and also related disorders such as insulin resistance and metabolic syndrome. Thanks to Lipigon's expertise in this area, AstraZeneca has chosen to enter into a cooperation agreement with the Company to develop LPL-based pharmaceuticals. Lipigon can receive up to $ 110 million in compensation at achieved milestones related to development and sales.
LIPIGON PHARMACEUTICALS
Social Links:
Industry:
Health Care Medical Pharmaceutical
Founded:
2010-01-01
Address:
Umeå, Vasterbottens Lan, Sweden
Country:
Sweden
Website Url:
http://www.lipigon.se
Total Employee:
1+
Status:
Active
Contact:
+46(0)705781768
Email Addresses:
[email protected]
Total Funding:
852.55 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Font Awesome
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Current Employees Featured
Founder
Stock Details
Investors List
Sciety
Sciety investment in Seed Round - Lipigon Pharmaceuticals
Almi Invest
Almi Invest investment in Seed Round - Lipigon Pharmaceuticals
Partnerinvest Norr
Partnerinvest Norr investment in Seed Round - Lipigon Pharmaceuticals
Official Site Inspections
http://www.lipigon.se
- Host name: websolutions.bequoted.com
- IP address: 81.170.239.161
- Location: Stockholm Sweden
- Latitude: 59.3307
- Longitude: 18.0718
- Timezone: Europe/Stockholm
- Postal: 110 57
More informations about "Lipigon Pharmaceuticals"
Lipigon
Lipigon utvecklar nya behandlingar för sjukdomar som orsakas av rubbningar i kroppens hantering av fetter, så kallade lipidrelaterade sjukdomar. Bolagets verksamhet bygger på över …See details»
Lipigon
Lipigon develops new treatments for diseases caused by disruptions in the body's handling of fats – known as lipid-related diseases. Our company's foundation is built upon over 50 years of …See details»
Management and Advisors - Lipigon
Lipigon has a network of leading scientific advisors in the field of lipid-related diseases. Their role involves providing guidance and expertise on specific matters, as well as optimizing the company's preclinical and clinical studies.See details»
Lipigon Pharmaceuticals AB | LinkedIn
We are lipid biology experts focusing on developing novel therapeutics for patients with lipid related disorders. Lipigon develops pharmaceuticals that are first- or best-in-class.See details»
Lipgion chooses Link Medical as their CRO
May 29, 2023 · Lipigon Pharmaceuticals AB (“Lipigon”), which develops drugs for diseases caused by disorders in the body’s handling of fats, announced earlier this week that they have …See details»
Lipigon Pharmaceuticals - Crunchbase Company Profile …
Lipigon Pharmaceuticals is specialized in fat metabolism and develops new blood lipids. Lipigon is currently focusing on developing drugs directed against the enzyme lipoprotein lipase (LPL). People with low activity at LPL have a higher …See details»
Lipigon celebrates office expansion while setting the …
Sep 28, 2023 · Lipigon develops new treatments for patients with lipid-related diseases, with the vision to enhance and extend the lives of those affected by high blood lipid levels. The company focuses on four key projects, with …See details»
Lipigon AB – a lipid biology specialist company - UBI
Lipigon is a lipid biology specialist company. It utilizes proprietary and unique know-how and technologies to discover and develop novel therapies for patients with lipid disorders and other cardio-metabolic risk factors.See details»
About Lipigon - Lipigon
Nov 21, 2024 · Lipigon is developing drugs for diseases caused by disruptions in the body's handling of lipids, where adequate treatment is currently lacking or limited, and where there is …See details»
Urban Paulsson new Chairman of the Board of Lipigon …
Jan 12, 2021 · Lipigon Pharmaceuticals AB, which develops new treatments for lipid-related diseases, announces that the board has elected Urban Paulsson as the new chairman of the board. Paulsson was elected to the board on October …See details»
Lipigon: First-in-human phase I trial with Lipigons lipid ... - Placera
May 31, 2022 · Lipigon Pharmaceuticals AB ("Lipigon") has announced that their drug candidate Lipisense has been given to humans for the first time. The phase I clinical trial began on …See details»
How Lipgon operates - Lipigon
Sep 2, 2021 · Lipigon Pharmaceuticals stands on a solid foundation of cutting-edge research, bolstered by collaborations with leading experts in various therapeutic technology domains. …See details»
Lipigon Pharmaceuticals AB (publ) (STO: LPGO) - Stock Analysis
6 days ago · Lipigon Pharmaceuticals AB (publ) develops drugs for lipid related diseases in Sweden. The company’s product pipeline consists of Lipisense project for the treatment of …See details»
Lipigon Pharmaceuticals signs USD 91 million deal with Leaderna …
Jun 30, 2023 · Umeå-based Lipigon Pharmaceuticals is celebrating the signing of a development and license agreement for its clinical-stage drug candidate Lipisense® with Leaderna …See details»
Lipigon applies for clinical trial Phase II for Lipisense ... - Placera
Nov 13, 2023 · Lipigon Pharmaceuticals AB (Lipigon) announces that the company has submitted an application for a Phase II clinical trial for its blood lipid-lowering drug candidate, Lipisense ®.See details»
Our History - Lipigon
Lipigon Pharmaceuticals AB was founded in 2010 by researchers at Umeå University. The extensive research spanning half a century by Thomas and Gunilla Olivecrona serves as the …See details»
Lipigon signs major new deal with Shanghai-listed HitGen - UBI
May 14, 2020 · Umeå-based Lipigon Pharmaceuticals AB has signed a major new agreement with Chinese biotech company HitGen to develop drug candidates that treat blood fat disorders and …See details»
First Patient Dosed in Phase II Clinical Trial of Lipisense®
Nov 21, 2024 · Lipigon’s pipeline includes three active projects: the RNA drug Lipisense ® targeting elevated triglycerides, with Phase II studies approved in February 2024; an RNA …See details»
Contact - Lipigon
556810-9077. Welcome to contact us!See details»
Gisela Sitbon new chairman of the board for Lipigon …
Apr 6, 2017 · Lipigon is focusing on the discovery and development of novel treatments for lipid disorders and related diseases. For more information please visit: http://www.lipigon.se. For …See details»